Main > ONCOLOGY (**) > Head & Neck>Squamous>C.>MET Or R > TREAT.: > USA. M. PembrolizuMAb > Indications> > >1st Line Treat.> > >MonoTherapy> > >(*) EU Approval Date: 2019. 11.20
>(*) EU Approval Date: 2019. 11.20's products
This section has no products